• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺鳞状细胞癌中克隆亚群数量的增加引发免疫相关基因的过表达。

Increased number of subclones in lung squamous cell carcinoma elicits overexpression of immune related genes.

作者信息

Song Myung Jin, Lee Sang Hoon, Kim Eun Young, Chang Yoon Soo

机构信息

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

Transl Lung Cancer Res. 2020 Jun;9(3):659-669. doi: 10.21037/tlcr-19-589.

DOI:10.21037/tlcr-19-589
PMID:32676328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7354124/
Abstract

BACKGROUND

Intratumoral heterogeneity is a cause of drug resistance that leads to treatment failure. We investigated the clinical implication of intratumoral heterogeneity inferred from the number of subclones that constituted a tumor and reasoned the etiology of subclonal expansion using RNA sequencing data.

METHODS

Simple nucleotide variation, clinical data, copy number variation, and RNA-sequencing data from 481 The Cancer Genome Atlas-Lung Squamous Cell Carcinoma (TCGA-LUSC) cases were obtained from the Genomic Data Commons data portal. Clonal status was estimated from the allele frequency of the mutated genes using the SciClone package.

RESULTS

The number of subclones that comprised a tumor had a positive correlation with the total mutations in a tumor (σ=0.477, P-value <0.001) and tumor stage (σ=0.111, P-value <0.015). Male LUSC tumors had a higher probability of having more subclones than female tumors (2.28 1.89, P-value =0.002, Welch Two Sample -test). On comparing the gene expression in the tumors that were comprised of five subclones with those of a single clone, 291 genes were found to be upregulated and 102 genes were found to be downregulated in the five subclone tumors. The upregulated genes included , , , , and , in order of magnitude of upregulation, and the biologic function of the upregulated genes was strongly enriched for the positive regulation of immune processes and inflammatory responses.

CONCLUSIONS

Male LUSC tumors were composed of a greater number of subclones than female tumors. The tumors with large numbers of subclones had overexpressed genes that positively regulated the immune processes and inflammatory responses more than tumors that consisted of a single clone.

摘要

背景

肿瘤内异质性是导致耐药进而致使治疗失败的一个原因。我们利用RNA测序数据研究了从构成肿瘤的亚克隆数量推断出的肿瘤内异质性的临床意义,并对亚克隆扩增的病因进行了推理。

方法

从基因组数据共享数据门户获取了481例癌症基因组图谱-肺鳞状细胞癌(TCGA-LUSC)病例的单核苷酸变异、临床数据、拷贝数变异和RNA测序数据。使用SciClone软件包根据突变基因的等位基因频率估计克隆状态。

结果

构成肿瘤的亚克隆数量与肿瘤中的总突变数(σ=0.477,P值<0.001)和肿瘤分期(σ=0.111,P值<0.015)呈正相关。男性LUSC肿瘤比亚克隆数量较少的女性肿瘤具有更高的概率(2.28对1.89,P值=0.002,Welch双样本检验)。在比较由五个亚克隆组成的肿瘤与单个克隆组成的肿瘤中的基因表达时,发现五个亚克隆肿瘤中有291个基因上调,102个基因下调。上调的基因按上调幅度依次包括、、、、,上调基因的生物学功能在免疫过程和炎症反应的正调控方面显著富集。

结论

男性LUSC肿瘤比女性肿瘤由更多数量的亚克隆组成。与由单个克隆组成的肿瘤相比,具有大量亚克隆的肿瘤具有更多正向调节免疫过程和炎症反应的过表达基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9b/7354124/d2f6a535aaaa/tlcr-09-03-659-fS.3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9b/7354124/e92108a3112e/tlcr-09-03-659-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9b/7354124/7b67d0d60555/tlcr-09-03-659-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9b/7354124/bd841a7d9253/tlcr-09-03-659-fS.1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9b/7354124/4ee7a7ddd5b3/tlcr-09-03-659-fS.2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9b/7354124/d2f6a535aaaa/tlcr-09-03-659-fS.3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9b/7354124/e92108a3112e/tlcr-09-03-659-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9b/7354124/7b67d0d60555/tlcr-09-03-659-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9b/7354124/bd841a7d9253/tlcr-09-03-659-fS.1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9b/7354124/4ee7a7ddd5b3/tlcr-09-03-659-fS.2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c9b/7354124/d2f6a535aaaa/tlcr-09-03-659-fS.3.jpg

相似文献

1
Increased number of subclones in lung squamous cell carcinoma elicits overexpression of immune related genes.肺鳞状细胞癌中克隆亚群数量的增加引发免疫相关基因的过表达。
Transl Lung Cancer Res. 2020 Jun;9(3):659-669. doi: 10.21037/tlcr-19-589.
2
Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutation.肿瘤克隆状态可预测具有EGFR-TKI敏感突变的肺腺癌的临床结局。
J Cancer. 2019 Aug 29;10(22):5549-5556. doi: 10.7150/jca.32897. eCollection 2019.
3
Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.肺鳞状细胞癌中肿瘤抑制基因的综合基因组和转录组分析及其对肿瘤微环境和免疫的作用
Front Immunol. 2021 Feb 25;12:598671. doi: 10.3389/fimmu.2021.598671. eCollection 2021.
4
Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.基于癌症干性的肺腺癌和肺鳞癌预后免疫相关基因特征。
Front Endocrinol (Lausanne). 2021 Oct 21;12:755805. doi: 10.3389/fendo.2021.755805. eCollection 2021.
5
Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.基于TCGA数据库和生物信息学分析的肺鳞状细胞癌中miR-136-5p关键靶基因及通路研究
Pathol Res Pract. 2018 May;214(5):644-654. doi: 10.1016/j.prp.2018.03.028. Epub 2018 Apr 5.
6
Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.基于铁死亡相关基因的肺鳞状细胞癌个体化预后标志物的鉴定和验证。
Thorac Cancer. 2021 Dec;12(23):3236-3247. doi: 10.1111/1759-7714.14195. Epub 2021 Oct 20.
7
Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.miR-182-5p 在肺鳞癌中的临床价值:一项结合 TCGA、GEO 数据和 RT-qPCR 验证的研究。
World J Surg Oncol. 2018 Apr 10;16(1):76. doi: 10.1186/s12957-018-1378-6.
8
Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.四个枢纽基因调节肿瘤浸润免疫细胞、肿瘤微环境中的抗肿瘤免疫以及肺鳞癌患者的生存结局。
Aging (Albany NY). 2021 Jan 10;13(3):3819-3842. doi: 10.18632/aging.202351.
9
Genomic evolutionary trajectory of metastatic squamous cell carcinoma of the lung.肺转移性鳞状细胞癌的基因组进化轨迹
Transl Lung Cancer Res. 2021 Apr;10(4):1792-1803. doi: 10.21037/tlcr-21-48.
10
Novel mutational landscapes and expression signatures of lung squamous cell carcinoma.肺鳞状细胞癌的新型突变图谱与表达特征
Oncotarget. 2017 Dec 27;9(7):7424-7441. doi: 10.18632/oncotarget.23716. eCollection 2018 Jan 26.

引用本文的文献

1
Clinical utility of repeated rebiopsy for EGFR T790M mutation detection in non-small cell lung cancer.重复活检用于非小细胞肺癌中表皮生长因子受体T790M突变检测的临床效用
Front Oncol. 2024 Aug 26;14:1452947. doi: 10.3389/fonc.2024.1452947. eCollection 2024.
2
Stabilization of EREG via STT3B-mediated N-glycosylation is critical for PDL1 upregulation and immune evasion in head and neck squamous cell carcinoma.通过 STT3B 介导的 N-糖基化稳定 EREG 对于头颈部鳞状细胞癌中 PD-L1 的上调和免疫逃逸至关重要。
Int J Oral Sci. 2024 Jul 1;16(1):47. doi: 10.1038/s41368-024-00311-1.
3
Microbiome Alteration in Lung Tissues of Tuberculosis Patients Revealed by Metagenomic Next-Generation Sequencing and Immune-Related Transcriptional Profile Identified by Transcriptome Sequencing.

本文引用的文献

1
Maftools: efficient and comprehensive analysis of somatic variants in cancer.Maftools:癌症体细胞变异的高效全面分析。
Genome Res. 2018 Nov;28(11):1747-1756. doi: 10.1101/gr.239244.118. Epub 2018 Oct 19.
2
Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer.当前和新兴的晚期鳞状细胞肺癌治疗选择。
J Thorac Oncol. 2018 Feb;13(2):165-183. doi: 10.1016/j.jtho.2017.11.111. Epub 2017 Nov 23.
3
Prevalence and detection of low-allele-fraction variants in clinical cancer samples.临床癌症样本中低频等位基因变异的流行和检测。
宏基因组下一代测序揭示肺结核患者肺部组织中的微生物组改变,转录组测序鉴定的免疫相关转录谱。
ACS Infect Dis. 2023 Dec 8;9(12):2572-2582. doi: 10.1021/acsinfecdis.3c00416. Epub 2023 Nov 17.
4
Transcriptomic profiles of age-related genes in female trachea and bronchus.女性气管和支气管中与年龄相关基因的转录组图谱。
Front Genet. 2023 Mar 8;14:1120350. doi: 10.3389/fgene.2023.1120350. eCollection 2023.
5
Unraveling the Impact of Intratumoral Heterogeneity on EGFR Tyrosine Kinase Inhibitor Resistance in -Mutated NSCLC.解析肿瘤内异质性对 EGFR 酪氨酸激酶抑制剂耐药的影响:-突变型 NSCLC 研究
Int J Mol Sci. 2023 Feb 18;24(4):4126. doi: 10.3390/ijms24044126.
Nat Commun. 2017 Nov 9;8(1):1377. doi: 10.1038/s41467-017-01470-y.
4
Tumour heterogeneity and resistance to cancer therapies.肿瘤异质性与癌症治疗耐药性。
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94. doi: 10.1038/nrclinonc.2017.166. Epub 2017 Nov 8.
5
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.克隆异质性与肿瘤演进:过去、现在与未来。
Cell. 2017 Feb 9;168(4):613-628. doi: 10.1016/j.cell.2017.01.018.
6
Integrating mutation variant allele frequency into clinical practice in myeloid malignancies.将突变变异等位基因频率纳入髓系恶性肿瘤的临床实践。
Hematol Oncol Stem Cell Ther. 2016 Sep;9(3):89-95. doi: 10.1016/j.hemonc.2016.04.003. Epub 2016 May 11.
7
Current practices and guidelines for clinical next-generation sequencing oncology testing.临床下一代测序肿瘤检测的当前实践与指南
Cancer Biol Med. 2016 Mar;13(1):3-11. doi: 10.28092/j.issn.2095-3941.2016.0004.
8
ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare.肺鳞状细胞癌中的ALK、ROS1和RET重排非常罕见。
Lung Cancer. 2016 Apr;94:22-7. doi: 10.1016/j.lungcan.2016.01.011. Epub 2016 Jan 21.
9
Evolutionary determinants of cancer.癌症的进化决定因素。
Cancer Discov. 2015 Aug;5(8):806-20. doi: 10.1158/2159-8290.CD-15-0439. Epub 2015 Jul 20.
10
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution.SciClone:推断克隆结构并追踪肿瘤进化的时空模式。
PLoS Comput Biol. 2014 Aug 7;10(8):e1003665. doi: 10.1371/journal.pcbi.1003665. eCollection 2014 Aug.